Drug Shortage Report for SAXENDA
Report ID | 253826 |
Drug Identification Number | 02437899 |
Brand name | SAXENDA |
Common or Proper name | Liraglutide injection |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LIRAGLUTIDE |
Strength(s) | 6MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | EA |
ATC code | A10BJ |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2025-10-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2025-04-01 |
Company comments | Due to Canadian supply constraints, we anticipate a shortage of Saxenda® in October 2025. We are working closely with our partners at Health Canada on solutions. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-04-01 | French | Compare |
v4 | 2025-04-01 | English | Compare |
v3 | 2025-04-01 | French | Compare |
v2 | 2025-04-01 | French | Compare |
v1 | 2025-04-01 | English | Compare |
Showing 1 to 5 of 5